AstraZeneca’s Dapagliflozin gets approval for Chronic Kidney Disease in India
365telugu.com online news,India,February12, 2021: AstraZeneca India (AstraZeneca Pharma India Limited), a leading science-led biopharmaceutical company, announced that they have received marketing authorisation for their anti-diabetic drug dapagliflozin, in India for…